GIH clinical research 2003-2004

The year in review

Research output: Contribution to journalArticle

Abstract

This article summarizes the clinical research advances in gastroenterology and hepatology that were reviewed during the Plenary Session of the American Gastroenterological Association's Annual Meeting in May 2004 in New Orleans, Louisiana. The clinical research advances included the efficacy of infliximab in the treatment of fistulizing Crohn's disease, survival after isolated intestinal transplantation, the role of endoscopic treatment of bleeding peptic ulcers and Barrett's esophagus, the recurrence of cancer after laparoscopic colectomy, the impact of microsatellite instability on the response to adjuvant chemotherapy with 5-fluorouracil (5-FU), the epidemiology of obesity and its response to low-carbohydrate diets, the potential role of gastrointestinal factors in the development of obesity, and, the newly appreciated condition, autoimmune pancreatitis with associated cholangitis. Clinical research advances will impact the management of digestive diseases.

Original languageEnglish (US)
Pages (from-to)1043-1047
Number of pages5
JournalClinical Gastroenterology and Hepatology
Volume2
Issue number12
DOIs
StatePublished - Dec 2004

Fingerprint

Gastroenterology
Obesity
Research
Carbohydrate-Restricted Diet
Microsatellite Instability
Cholangitis
Barrett Esophagus
Colectomy
Adjuvant Chemotherapy
Esophageal Neoplasms
Disease Management
Peptic Ulcer
Fluorouracil
Crohn Disease
Pancreatitis
Epidemiology
Transplantation
Hemorrhage
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

GIH clinical research 2003-2004 : The year in review. / Camilleri, Michael.

In: Clinical Gastroenterology and Hepatology, Vol. 2, No. 12, 12.2004, p. 1043-1047.

Research output: Contribution to journalArticle

@article{67d463c49d394bda8c3688b0de3f705d,
title = "GIH clinical research 2003-2004: The year in review",
abstract = "This article summarizes the clinical research advances in gastroenterology and hepatology that were reviewed during the Plenary Session of the American Gastroenterological Association's Annual Meeting in May 2004 in New Orleans, Louisiana. The clinical research advances included the efficacy of infliximab in the treatment of fistulizing Crohn's disease, survival after isolated intestinal transplantation, the role of endoscopic treatment of bleeding peptic ulcers and Barrett's esophagus, the recurrence of cancer after laparoscopic colectomy, the impact of microsatellite instability on the response to adjuvant chemotherapy with 5-fluorouracil (5-FU), the epidemiology of obesity and its response to low-carbohydrate diets, the potential role of gastrointestinal factors in the development of obesity, and, the newly appreciated condition, autoimmune pancreatitis with associated cholangitis. Clinical research advances will impact the management of digestive diseases.",
author = "Michael Camilleri",
year = "2004",
month = "12",
doi = "10.1016/S1542-3565(04)00448-3",
language = "English (US)",
volume = "2",
pages = "1043--1047",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - GIH clinical research 2003-2004

T2 - The year in review

AU - Camilleri, Michael

PY - 2004/12

Y1 - 2004/12

N2 - This article summarizes the clinical research advances in gastroenterology and hepatology that were reviewed during the Plenary Session of the American Gastroenterological Association's Annual Meeting in May 2004 in New Orleans, Louisiana. The clinical research advances included the efficacy of infliximab in the treatment of fistulizing Crohn's disease, survival after isolated intestinal transplantation, the role of endoscopic treatment of bleeding peptic ulcers and Barrett's esophagus, the recurrence of cancer after laparoscopic colectomy, the impact of microsatellite instability on the response to adjuvant chemotherapy with 5-fluorouracil (5-FU), the epidemiology of obesity and its response to low-carbohydrate diets, the potential role of gastrointestinal factors in the development of obesity, and, the newly appreciated condition, autoimmune pancreatitis with associated cholangitis. Clinical research advances will impact the management of digestive diseases.

AB - This article summarizes the clinical research advances in gastroenterology and hepatology that were reviewed during the Plenary Session of the American Gastroenterological Association's Annual Meeting in May 2004 in New Orleans, Louisiana. The clinical research advances included the efficacy of infliximab in the treatment of fistulizing Crohn's disease, survival after isolated intestinal transplantation, the role of endoscopic treatment of bleeding peptic ulcers and Barrett's esophagus, the recurrence of cancer after laparoscopic colectomy, the impact of microsatellite instability on the response to adjuvant chemotherapy with 5-fluorouracil (5-FU), the epidemiology of obesity and its response to low-carbohydrate diets, the potential role of gastrointestinal factors in the development of obesity, and, the newly appreciated condition, autoimmune pancreatitis with associated cholangitis. Clinical research advances will impact the management of digestive diseases.

UR - http://www.scopus.com/inward/record.url?scp=11144298732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144298732&partnerID=8YFLogxK

U2 - 10.1016/S1542-3565(04)00448-3

DO - 10.1016/S1542-3565(04)00448-3

M3 - Article

VL - 2

SP - 1043

EP - 1047

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 12

ER -